logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Fondazione I.R.C.C.S. Policlinico San Matteo

+3903825011
Source: Site record.
https://www.sanmatteo.org/site/home.html

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Fondazione I.R.C.C.S. Policlinico San Matteo is a public institution of national and international importance with a strong university presence.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. General hospital

Business Subcategory

Source: Human-provided. General hospital
Source: Human-provided. University hospital
Source: Trial-derived.
373Total Trials
Source: Trial-derived.
126Recruiting Trials
Source: Trial-derived.
142Active Trials
Source: Trial-derived.
1Completed Trials
Source: Trial-derived.
484Unique Conditions
Source: Trial-derived.
330Unique Sponsors

Conditions

Source: Trial-derived. Multiple Myeloma (17)Source: Trial-derived. Pulmonary Arterial Hypertension (10)Source: Trial-derived. Breast Cancer (9)Source: Trial-derived. Ulcerative Colitis (8)Source: Trial-derived. Sepsis (6)Source: Trial-derived. AL Amyloidosis (5)Source: Trial-derived. Amyloidosis (5)Source: Trial-derived. Crohn's Disease (5)

Sponsors

Source: Trial-derived. Fondazione IRCCS Policlinico San Matteo di Pavia (126)Source: Trial-derived. Merck Sharp & Dohme LLC (15)Source: Trial-derived. Janssen Research & Development, LLC (13)Source: Trial-derived. Pfizer (11)Source: Trial-derived. Takeda (10)Source: Trial-derived. University of Pavia (9)Source: Trial-derived. Hoffmann-La Roche (8)Source: Trial-derived. Celgene (7)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic source (eSource) system

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Echocardiography
Source: AI-inferred. CT Scan
Source: AI-inferred. Six-minute walk test
Source: AI-inferred. X-Ray
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. MRI
Source: AI-inferred. PET-CT

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Clinical microbiology culture

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Cardiac catheterisation or electrophysiology procedures
Source: AI-inferred. Surgery / operating room

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Minimal residual disease testing
Source: AI-inferred. Clostridium difficile toxin testing
Source: AI-inferred. Electronic patient-reported outcome (e-diary) system
Source: AI-inferred. Electronic patient-reported outcome (ePRO) diary system
Source: AI-inferred. HIV-1 tropism testing
Source: AI-inferred. Measurable residual disease (MRD) assessment
Source: AI-inferred. Minimal residual disease (MRD) testing
Source: AI-inferred. Participant mobile study app (eDiary/ePRO)